Multi-Omics Analyses, Cell Experiments, And Network Pharmacology Tools Identified Key Proteins And Candidate Drugs For Alopecia Areata Treatment

This study used multi-omics analyses, cell experiments, and network pharmacology tools to identify key proteins and potential drug targets for alopecia areata (AA) treatment. Researchers analyzed data from over 100,000 participants and identified six plasma proteins with significant causal associations with AA, focusing on DEFB1, HGFAC, and CYB5D2 as promising drug targets. DEFB1 was linked to autoimmune responses affecting hair follicles, and cimigenol was identified as a potential inhibitor of DEFB1. HGFAC was found to promote hair regrowth through the Wnt/β-catenin pathway. The study suggests these proteins as novel drug targets for AA, offering pathways for developing effective treatments, though further research is needed.